Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4 Week Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of AGR Tablet in the Treatment of Perennial Allergic Rhinitis in Korean : a Phase III Clinical Trial Bridging Study

NCT01982916 is registered in ClinicalTrials.gov with Ahn-Gook Pharmaceuticals Co.,Ltd as lead sponsor.

NCT NCT01982916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01982916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4 Week Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of AGR Tablet in the Treatment of Perennial Allergic Rhinitis in Korean : a Phase III Clinical Trial Bridging Study
Lead sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2013
Completion date
January 31, 2015
Enrollment
324 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, non-seasonal allergic rhinitis, perennial allergic rhinitis